Jong-Ho Kim

Years Active: 2020-2023
Publications (10 Years): 6

This page only lists publications with an associated author ORCID identifier.

Publications

Gye Lim Kim, Byeongmin Park, Eun Hyang Jang, Jaeun Gu, Seo Ra Seo, Hyein Cheung, Hyo Jung Lee, Sangmin Lee, Jong-Ho Kim
Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide. Pharmaceutics 15 (2) (2023)
Gye Lim Kim, Byeongmin Park, Eun Hyang Jang, Jaeun Gu, Seo Ra Seo, Hyein Cheung, Hyo Jung Lee, Sangmin Lee, Jong-Ho Kim
Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide. Pharmaceutics 15 (2) (2023)
Gye Lim Kim, Byeongmin Park, Eun Hyang Jang, Jaeun Gu, Seo Ra Seo, Hyein Cheung, Hyo Jung Lee, Sangmin Lee, Jong-Ho Kim
Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide. Pharmaceutics 15 (2) (2023)
Chaeeun Bang, Min Gyu Park, In Kyung Cho, Da-Eun Lee, Gye Lim Kim, Eun Hyang Jang, Man Kyu Shim, Hong Yeol Yoon, Sangmin Lee, Jong-Ho Kim
Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy. Biomaterials research 27 (1) (2023)
In Kyung Cho, Man Kyu Shim, Wooram Um, Jong-Ho Kim, Kwangmeyung Kim
Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer. Molecules (Basel, Switzerland) 27 (8) (2022)
Jimin Do, Namkwon Kim, Seung Ho Jeon, Min Sung Gee, Yeon-Joo Ju, Jong-Ho Kim, Myung Sook Oh, Jong Kil Lee
Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice. International journal of molecular sciences 21 (12) (2020)

Jong-Ho Kim.css-eqlu8i{font-size:small;padding-left:4px;}